We are live on ! Find out more
3C

325 Capital Portfolio holdings

AUM $419M
1-Year Est. Return 75.74%
This Fund
S&P 500
This Quarter Est. Return
+43.52%
1 Year Est. Return
+75.74%
3 Year Est. Return
+225.71%
5 Year Est. Return
10 Year Est. Return
AUM
$419M
AUM Growth
+$145M
Cap. Flow
+$43.3M
Cap. Flow %
10.31%
Top 10 Hldgs %
97.77%
Holding
12
New
Increased
5
Reduced
2
Closed

Top Buys

Rank Stock Value
1
SPIR icon
Spire Global
SPIR
+$20.3M
2
MGNI icon
Magnite
MGNI
+$20.2M
3
AIOT
PowerFleet Inc
AIOT
+$5.07M
4
LFCR icon
Lifecore Biomedical
LFCR
+$3.69M
5
BLBD icon
Blue Bird Corp
BLBD
+$2.14M

Top Sells

Rank Stock Value
1
ASTH icon
Astrana Health
ASTH
+$8.11M
2
MSAI icon
MultiSensor AI
MSAI
+$24

Sector Composition

Rank Sector Weight
1 Industrials 26.55%
2 Healthcare 23.53%
3 Communication Services 15.44%
4 Consumer Staples 15.15%
5 Technology 11.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTH icon
1
Astrana Health
ASTH
$1.88B
$74.9M 17.85%
1,613,843
-225,233
-12% -$8.11M
MGNI icon
2
Magnite
MGNI
$3.4B
$64.8M 15.44%
3,412,694
+1,407,307
+70% +$20.2M
APEI icon
3
American Public Education
APEI
$842M
$63.6M 15.15%
1,183,732
BLBD icon
4
Blue Bird Corp
BLBD
$1.88B
$56.2M 13.39%
711,390
+31,564
+5% +$2.14M
SPIR icon
5
Spire Global
SPIR
$535M
$55.2M 13.16%
2,966,932
+1,091,932
+58% +$20.3M
MPAA icon
6
Motorcar Parts of America
MPAA
$218M
$30.9M 7.37%
2,018,795
DBD icon
7
Diebold Nixdorf
DBD
$2.29B
$20.6M 4.91%
242,084
AIOT
8
PowerFleet Inc
AIOT
$409M
$20.2M 4.82%
5,283,000
+1,445,590
+38% +$5.07M
LFCR icon
9
Lifecore Biomedical
LFCR
$172M
$15.2M 3.62%
2,895,881
+733,415
+34% +$3.69M
BTMD icon
10
Biote Corp
BTMD
$45M
$8.6M 2.05%
4,548,127
TACT icon
11
Transact Technologies
TACT
$53.4M
$5.91M 1.41%
1,011,789
MSAI icon
12
MultiSensor AI
MSAI
$11.8M
$3.45M 0.82%
662,244
-4
-0% -$24

Similar funds

325 Capital's Q2 2026 Portfolio in Review

As of Q2 2026, 325 Capital held 12 positions worth $419M, up 53% from $274M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

325 Capital deployed $43.3M of net new capital in Q2 2026, adding to 5 existing holdings.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Astrana Health, an estimated $8.11M trimmed.

  • 325 Capital added most to Spire Global in Q2 2026, an estimated $20.3M increase.
  • 325 Capital's biggest Q2 2026 reduction was Astrana Health, cutting an estimated $8.11M.
  • 325 Capital's ten largest holdings make up 98% of its $419M portfolio in Q2 2026.
  • 325 Capital opened 0 new positions and closed 0 in Q2 2026.
  • 325 Capital's portfolio value rose 53% quarter-over-quarter to $419M.

Based on 325 Capital's 13F filing for Q2 2026, filed 14 Aug 2026.